Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients
      QxMD      Google Scholar   
Citation:
Br J Cancer vol 126 (2) 265-274
Year:
2022
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Meta-Analysis
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
11
Parents:
2462   3377  
Children:
None
Program:
TRP
Primary Committee:
PPP
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171, UG1CA233253, UG1CA233327, UG1CA233373, São Paulo Research Foundation-FAPESP (2018/04491-2)  
Corr. Author:
 
Authors:
                                             
Networks:
CA824, LAPS-IL057, LAPS-MA036, LAPS-NC007, NC002, NY018   
Study
Alliance-A152114
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-40502, CALGB-40503, CALGB-80303, CALGB-90401
Phases:
N/A, 3
Keywords:
Cancer genetics, Predictive markers